IBD PRECIS Trademark

Trademark Overview


On Wednesday, July 9, 2025, a trademark application was filed for IBD PRECIS with the United States Patent and Trademark Office. The USPTO has given the IBD PRECIS trademark a serial number of 99275743. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, January 6, 2026. This trademark is owned by Prometheus Laboratories Inc.. The IBD PRECIS trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical diagnostic testing, monitoring and reporting services in the field of inflammatory bowel disease; Providing medical information in the nature of differential diagnosis, characterization of ulcerative colitis and Crohn’s disease and analysis of markers, of inflammatory bowel disease

Providing medical and scientific research information in the field of differential diagnosis, characterization of ulcerative colitis and Crohn’s disease, and analysis of markers, of inflammatory bowel disease; Laboratory research in the field of differential diagnosis, characterization of ulcerative colitis and Crohn’s disease and analysis of markers, of inflammatory bowel disease
ibd precis

General Information


Serial Number99275743
Word MarkIBD PRECIS
Filing DateWednesday, July 9, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, January 6, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical diagnostic testing, monitoring and reporting services in the field of inflammatory bowel disease; Providing medical information in the nature of differential diagnosis, characterization of ulcerative colitis and Crohn’s disease and analysis of markers, of inflammatory bowel disease
Goods and ServicesProviding medical and scientific research information in the field of differential diagnosis, characterization of ulcerative colitis and Crohn’s disease, and analysis of markers, of inflammatory bowel disease; Laboratory research in the field of differential diagnosis, characterization of ulcerative colitis and Crohn’s disease and analysis of markers, of inflammatory bowel disease
Pseudo MarkINFLAMMATORY BOWEL DISEASE PRECIS

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 9, 2025
Primary Code042
First Use Anywhere DateSunday, November 30, 2025
First Use In Commerce DateSunday, November 30, 2025

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 9, 2025
Primary Code044
First Use Anywhere DateSunday, November 30, 2025
First Use In Commerce DateSunday, November 30, 2025

Trademark Owner History


Party NamePrometheus Laboratories Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Wednesday, July 9, 2025NEW APPLICATION ENTERED
Wednesday, July 9, 2025APPLICATION FILING RECEIPT MAILED
Friday, November 14, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 28, 2025ASSIGNED TO EXAMINER
Friday, December 26, 2025NON-FINAL ACTION WRITTEN
Friday, December 26, 2025NON-FINAL ACTION E-MAILED
Friday, December 26, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 6, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 6, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 6, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 6, 2026TEAS AMENDMENT OF USE RECEIVED
Tuesday, January 6, 2026USE AMENDMENT FILED
Tuesday, January 6, 2026AMENDMENT TO USE PROCESSING COMPLETE